These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The clinical significance of CA-125 in pulmonary tuberculosis. Kim ES, Park KU, Song J, Lim HJ, Cho YJ, Yoon H, Lee J, Lee CT, Park JS. Tuberculosis (Edinb); 2013 Mar; 93(2):222-6. PubMed ID: 23414674 [Abstract] [Full Text] [Related]
25. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB. Chien JY, Chen YT, Shu CC, Lee JJ, Wang JY, Yu CJ, Yang PC. Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018 [Abstract] [Full Text] [Related]
26. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis. van der Kuyp F, Mahan CS. Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266 [Abstract] [Full Text] [Related]
27. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P, Darbyshire J, Zumla A, LUSKAR collaboration. Lancet; 2002 Oct 05; 360(9339):1050-5. PubMed ID: 12383985 [Abstract] [Full Text] [Related]
29. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7). Butov DA, Efremenko YV, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS. Immunotherapy; 2013 Oct 05; 5(10):1047-54. PubMed ID: 24088075 [Abstract] [Full Text] [Related]
30. [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis]. Luo Y, Lu S, Guo S. Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb 05; 23(2):85-8. PubMed ID: 11778496 [Abstract] [Full Text] [Related]
31. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Thorax; 2008 Jul 05; 63(7):627-34. PubMed ID: 18250184 [Abstract] [Full Text] [Related]
37. Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10. Xu L, Cui G, Jia H, Zhu Y, Ding Y, Chen J, Lu C, Ye P, Gao H, Li L, Ma W, Lyu J, Diao H. J Transl Med; 2016 Jun 16; 14(1):179. PubMed ID: 27311307 [Abstract] [Full Text] [Related]
38. Prevalence of smear negative pulmonary tuberculosis among patients visiting St. Peter's Tuberculosis Specialized Hospital, Addis Ababa, Ethiopia. Desta K, Asrat D, Lemma E, Gebeyehu M, Feleke B. Ethiop Med J; 2009 Jan 16; 47(1):17-24. PubMed ID: 19743776 [Abstract] [Full Text] [Related]